Harsiwi Candra Sari, Haliza Hasnia Putri, Pinantun Wiguna Kusuma Paksi, Gabriel Hidayat, Silmi Rahma Amelia, Citra Deliana Dewi Sundari, Heni Rachmawati, Atthar Luqman Ivansyah, Fahdzi Muttaqien, Ferry Iskandar
Since the emergence of SARS-CoV-2 in 2020, the world has faced a global pandemic, emphasizing the urgent need for effective treatments to combat COVID-19. This study explores the use of green-synthesized carbon-based nanomaterials as potential inhibitors of ACE2, a critical receptor for SARS-CoV-2 entry into host cells. Specifically, the study examines four carbon-based nanomaterials, namely, CD1, CD2, CD3, and CD4 in amino, graphitic, pyridinic, and pyrrolic forms, respectively, synthesized from curcumin, to investigate their binding affinity with ACE2...
April 9, 2024: ACS Omega